Pemafibrate treatment decreased ALT‐AST and creatinine plasma levels compared with vehicle‐treated controls 24 h after sepsis, indicating improved liver and kidney function (Fig 6A and B, AST levels in Fig EV3G). The gene discussed is GPT; the disease is Sepsis.